CAR1 Antibodies

CAR1 Antibodies

CAR1 antibodies target the Carbonic Anhydrase-Related Protein 1 (CAR1), a member of the carbonic anhydrase family. CAR1 is primarily known for its role in catalyzing the reversible conversion of carbon dioxide to bicarbonate and protons, facilitating pH regulation in various tissues. These antibodies are highly specific and can be used in detecting and quantifying CAR1 expression in research and diagnostic applications.

Content

CAR1 is expressed in several tissues, including the gastrointestinal tract, kidneys, and reproductive system. It has been studied for its role in pH balance, ion transport, and other physiological processes. CAR1 is also implicated in certain pathological conditions, including cancers and metabolic disorders. CAR1 antibodies are developed to bind specifically to the CAR1 protein, enabling detailed investigation of its structure, expression levels, and functions. 

Application

CAR1 antibodies are utilized in various applications such as:

• Western Blotting (WB): For the detection and analysis of CAR1 protein expression levels in cell and tissue lysates.
• Immunohistochemistry (IHC): Employed in tissue section staining to localize CAR1 expression within tissues, providing insights into tissue-specific functions.
• Enzyme-Linked Immunosorbent Assay (ELISA): For quantifying CAR1 levels in different biological samples, including serum and cell extracts.
• Flow Cytometry: To measure CAR1 expression in individual cells, aiding in cellular phenotyping and diagnostic applications.
• Immunoprecipitation (IP): Utilized to isolate CAR1 protein from complex mixtures, facilitating further studies on protein interactions and functional assays.

These applications of CAR1 antibodies are critical for understanding the physiological and pathological roles of CAR1, aiding in potential therapeutic targeting and diagnostic tool development.